A Rh-catalyzed 1,2-sulfur migration/aza-Diels–Alder cascade initiated by aza-vinyl carbenoids from sulfur-tethered N-sulfonyl-1,2,3-triazoles
作者:Yu Jiang、Xiang-Ying Tang、Min Shi
DOI:10.1039/c4cc08829h
日期:——
A novel Rh(ii) catalyzed intramolecular 1,2-sulfur migration/intermolecular aza-Diels–Alder cascade of sulfur-tetheredN-sulfonyl-1,2,3-triazoles has been developed, efficiently affording sulfur-containing tetrahydropyridine derivatives.
Reactions of HDDA-Derived Benzynes with Sulfides: Mechanism, Modes, and Three-Component Reactions
作者:Junhua Chen、Vignesh Palani、Thomas R. Hoye
DOI:10.1021/jacs.6b01025
日期:2016.4.6
We report here reactions of alkyl sulfides with benzynes thermally generated by the hexadehydro-Diels-Alder (HDDA) cycloisomerization. The initially produced 1,3-betaine (o-sulfonium/aryl carbanion) undergoes intramolecular proton transfer to generate a more stable S-aryl sulfur ylide. This can react in various manners, including engaging weak acids (HA) in the reaction medium. This can produce transient
Synthesis of dienes with 1,1-Captodative substitution
作者:N Stévenart-De Mesmaeker、R Merényi、H.G Viehe
DOI:10.1016/s0040-4039(00)96155-0
日期:1987.1
1,1-Captodative butadienes carrying amino, thioether or methoxy groups combined with nitrile and ester substituents were synthesized via a [3,2] sigmatropic rearrangement, an alkylation-halogenation-dehydrohalogenation sequence or via the Wittig-Horner reaction.
STEVENART-DE, MESMAEKER N.;MERENYI, R.;VIEHE, H. G., TETRAHEDRON LETT., 28,(1987) N 23, 2591-2594
作者:STEVENART-DE, MESMAEKER N.、MERENYI, R.、VIEHE, H. G.
DOI:——
日期:——
[EN] REVERSIBLE MACROCYCLIC KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE RÉVERSIBLES MACROCYCLIQUES
申请人:[en]NETHERLANDS TRANSLATIONAL RESEARCH CENTER HOLDING B.V
公开号:WO2023110936A1
公开(公告)日:2023-06-22
The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors. Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicament, in particular for the treatment specific kinase mediated disorders, such as cancer.